Feraccru

RSS

ferric maltol

Authorised
This medicine is authorised for use in the European Union.

Overview

An overview of Feraccru and why it is authorised in the EU

Feraccru is an iron-containing medicine used to treat iron deficiency (lack of iron) in adults.

Feraccru contains the active substance ferric maltol.

This EPAR was last updated on 18/07/2018

Authorisation details

Product details
Name
Feraccru
Agency product number
EMEA/H/C/002733
Active substance
ferric maltol
International non-proprietary name (INN) or common name
ferric maltol
Therapeutic area (MeSH)
Anemia, Iron-Deficiency
Anatomical therapeutic chemical (ATC) code
B03AB
Publication details
Marketing-authorisation holder
Shield TX (UK) Limited
Revision
6
Date of issue of marketing authorisation valid throughout the European Union
18/02/2016
Contact address
Northern Design Centre
Baltic Business Centre
Gateshead Quays NE8 3DF
United Kingdom

Product information

15/06/2018 Feraccru - EMEA/H/C/002733 - IB/0015

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

ANTIANEMIC PREPARATIONS

Therapeutic indication

Feraccru is indicated in adults for the treatment of iron deficiency anaemia (IDA) in patients with inflammatory bowel disease (IBD).

Assessment history

How useful was this page?

Add your rating
Average
1 rating